3 eye-opening quotes from the CEO who raised the price on EpiPens.

In August 2016, pharmaceutical company Mylan became the latest health company to fall under fire for price gouging.

Over the course of seven years, they'd carefully managed to inflate the list price of EpiPen by nearly 500%, along with price-hikes on more than 30 other products too. That's pretty absurd, considering that some people, including fellow pharmaceutical-makers, say EpiPen ingredients are inexpensive and the pen can cost less than $20 to make. Plus, EpiPen already accounts for 40% of Mylan's operating profits.

At the height of this debacle, Mylan CEO Heather Bresch spoke with CNBC to offer insights on the inner workings of the pharmaceutical industry. And her answers actually revealed a lot about health care in America.


Mylan CEO Heather Bresch. Photo by Neilson Barnard/Getty Images.

1. "This isn't an EpiPen issue. This isn't a Mylan issue. This is a health care issue," she said, when asked about government regulations.

There's a whole lot of shady business going on in the health care industry right now, and it's not limited to Mylan.

There was the Turing Pharmaceutical's infamous 5,000% overnight price hike on Daraprim in December 2015, and KV Pharmaceuticals cornered the market on a drug to help prevent premature births and then slapped a markup on it of more than 1,000%. More recently, pharma company Valeant jacked up the price of some generic heart medications it had acquired by up to seven-fold or more.

Photo by Drew Angerer/Getty Images.

2. When an anchor pointed out the bad headlines on Mylan, she responded, "We have given out 700,000 free EpiPens. We stocked 65,000 public schools in this country. ... We're now passing legislation,  30 states to have them in restaurants, hotels."

She also said, "We want everyone who needs an EpiPen to have one."

On the surface level, this is good, right? But it starts to get messy when you look a little closer.

Mylan has already spent millions of dollars in lobbying under the auspices of improving education and awareness about anaphylactic shock. As a result, they've managed to get federal guidelines rewritten to make EpiPens available to anyone, instead of just those with dangerous allergies, and have pushed to require schools and soon also restaurants and hotels to carry the treatment.

For those at risk for deathly allergies, this increased presence of EpiPen is certainly a good thing.

Photo Illustration by Joe Raedle/Getty Images.

But it's even better for Mylan, which not only gets to increase its customer base, but also receives a generous tax break for all of those EpiPen donations. Combined with their recent corporate move to the Netherlands, this means that Mylan now pays a distinctly low U.S. federal tax rate.

And that's with you buying EpiPens at a 500% markup.

Photo by Lucas Trieb/AFP/Getty Images.

3. So how do you fix the problem? Bresch's advice was this: "Patients need to get engaged in their health care. [...] There's no transparency, there's no clarity, and no one knows what anything costs."

She went on to say, "Anytime you're shopping for anything, you know what that product is going to cost when you walk up to the counter. Only in health care ... do you walk up to that pharmacy counter, you could have paid $25 yesterday and you're paying $600, $1,000, $2,000."

Photo by Matt Cardy/Getty Images.

Health care costs are muddled, confusing, and seem to change arbitrarily. Even with the regulations that have been put in place by the Affordable Care Act, the U.S. health care system still feels like a mysterious labyrinth where a wrong turn can lead you into either a gold mine or a terrifying confrontation with a surly minotaur.

And if you do have the time, energy, and brain space required to engage more closely with your health care? You're often straddled with a choice between no transparency or being inundated with too much confusing information to make an informed decision.

Photo by Mario Tama/Getty Images.

Yes, the U.S. health care system is still messed up. But the answer to the problem is not to exploit the people who are paying out of pocket.

The problem here isn't consumers or Obamacare or the distribution supply. It's greed. And this time around, Mylan is responsible for the mess.

So what can we, the consumers, do about it? Maybe it's time we listened to Bresch and really got informed and engaged with our health care — by refusing to buy from companies like Mylan whenever there's an option. Then we can reach out to our congresspeople and tell 'em to get their act together.

It might not sound like much, but it's a start.

Simon & Garfunkel's song "Bridge Over Troubled Water" has been covered by more than 50 different musical artists, from Aretha Franklin to Elvis Presley to Willie Nelson. It's a timeless classic that taps into the universal struggle of feeling down and the comfort of having someone to lift us up. It's beloved for its soothing melody and cathartic lyrics, and after a year of pandemic challenges, it's perhaps more poignant now than ever.

A few years a go, American singer-songwriter Yebba Smith shared a solo a capella version of a part of "Bridge Over Troubled Water," in which she just casually sits and sings it on a bed. It's an impressive rendition on its own, highlighting Yebba's soulful, effortless voice.

But British singer Jacob Collier recently added his own layered harmony tracks to it, taking the performance to a whole other level.

Keep Reading Show less
Images courtesy of John Scully, Walden University, Ingrid Scully
True

Since March of 2020, over 29 million Americans have been diagnosed with COVID-19, according to the CDC. Over 540,000 have died in the United States as this unprecedented pandemic has swept the globe. And yet, by the end of 2020, it looked like science was winning: vaccines had been developed.

In celebration of the power of science we spoke to three people: an individual, a medical provider, and a vaccine scientist about how vaccines have impacted them throughout their lives. Here are their answers:

John Scully, 79, resident of Florida

Photo courtesy of John Scully

When John Scully was born, America was in the midst of an epidemic: tens of thousands of children in the United States were falling ill with paralytic poliomyelitis — otherwise known as polio, a disease that attacks the central nervous system and often leaves its victims partially or fully paralyzed.

"As kids, we were all afraid of getting polio," he says, "because if you got polio, you could end up in the dreaded iron lung and we were all terrified of those." Iron lungs were respirators that enclosed most of a person's body; people with severe cases often would end up in these respirators as they fought for their lives.

John remembers going to see matinee showings of cowboy movies on Saturdays and, before the movie, shorts would run. "Usually they showed the news," he says, "but I just remember seeing this one clip warning us about polio and it just showed all these kids in iron lungs." If kids survived the iron lung, they'd often come back to school on crutches, in leg braces, or in wheelchairs.

"We all tried to be really careful in the summer — or, as we called it back then, 'polio season,''" John says. This was because every year around Memorial Day, major outbreaks would begin to emerge and they'd spike sometime around August. People weren't really sure how the disease spread at the time, but many believed it traveled through the water. There was no cure — and every child was susceptible to getting sick with it.

"We couldn't swim in hot weather," he remembers, "and the municipal outdoor pool would close down in August."

Then, in 1954 clinical trials began for Dr. Jonas Salk's vaccine against polio and within a year, his vaccine was announced safe. "I got that vaccine at school," John says. Within two years, U.S. polio cases had dropped 85-95 percent — even before a second vaccine was developed by Dr. Albert Sabin in the 1960s. "I remember how much better things got after the vaccines came out. They changed everything," John says.

Keep Reading Show less